Overview

Timed Aspirin Chronobiome Study

Status:
Not yet recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
To determine whether timed administration of aspirin ameliorates the effects of celecoxib on blood pressure.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Pennsylvania
Treatments:
Aspirin
Celecoxib